General Catalyst Group Management, LLC — 13F Holdings & Portfolio
CIK 1637946 · latest 13F-HR filed 2026-08-17
General Catalyst Group Management, LLC manages $188.5M in 13F-reported U.S. long-equity assets across 14 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are AVBP (27.55%), PBLS (23.24%), CART (17.85%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 4 new positions, exited 2, added to 8, and trimmed 1.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
20 UNIVERSITY ROAD, 4TH FLOOR
CAMBRIDGE, MA 02138
$188.5M
Long-equity book
14
Distinct positions
2026-06-30
Filed 2026-08-17
+4 / −2 / ↑8 / ↓1
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- ArriVent BioPharma, Inc.$17.4M +50.6%
- Maplebear, Inc.$7.0M +26.4%
- Fractyl Health, Inc.$1.6M +73.5%
- Eikon Therapeutics, Inc.$753.9K +23.3%
- Ethos Technologies, Inc.$517.0K +62.4%
New Positions
- Parabilis Medicines, Inc.$43.8M
- Odyssey Therapeutics, Inc.$15.2M
- Doordash Inc.$525.9K
- Carvana Co$425.5K
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | ArriVent BioPharma, Inc. | AVBP | 04272N102 | $51.9M | 27.55% | 1,494,786 | SH |
| 2 | Parabilis Medicines, Inc. | PBLS | 698955101 | $43.8M | 23.24% | 1,600,937 | SH |
| 3 | Maplebear, Inc. | CART | 565394103 | $33.7M | 17.85% | 710,711 | SH |
| 4 | Maze Therapeutics, Inc. | MAZE | 578784100 | $30.9M | 16.40% | 1,035,910 | SH |
| 5 | Odyssey Therapeutics, Inc. | ODTX | 67613T104 | $15.2M | 8.04% | 810,272 | SH |
| 6 | Eikon Therapeutics, Inc. | EIKN | 282564103 | $4.0M | 2.11% | 305,233 | SH |
| 7 | Fractyl Health, Inc. | GUTS | 35168W103 | $3.9M | 2.06% | 4,884,186 | SH |
| 8 | Ethos Technologies, Inc. | LIFE | 29765A101 | $1.3M | 0.71% | 74,179 | SH |
| 9 | Coupang Inc. | CPNG | 22266T109 | $949.7K | 0.50% | 54,677 | SH |
| 10 | Amazon.com Inc. | AMZN | 023135106 | $925.2K | 0.49% | 3,882 | SH |
| 11 | Meta Platforms Inc. | META | 30303M102 | $743.5K | 0.39% | 1,320 | SH |
| 12 | Doordash Inc. | DASH | 25809K105 | $525.9K | 0.28% | 2,850 | SH |
| 13 | Carvana Co | CVNA | 146869102 | $425.5K | 0.23% | 6,465 | SH |
| 14 | Figma, Inc. | FIG | 316841105 | $268.5K | 0.14% | 14,845 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-17 | $188.5M | 14 | 0001637946-26-000002 |
| 2026-03-31 | 2026-05-15 | $183.6M | 12 | 0000905148-26-002373 |
| 2025-12-31 | 2026-02-17 | $221.7M | 7 | 0000905148-26-000847 |
| 2025-09-30 | 2025-11-14 | $3.04B | 8 | 0000905148-25-004012 |